ZA982562B - Chemically and thermally stable norastemizole formulations - Google Patents

Chemically and thermally stable norastemizole formulations

Info

Publication number
ZA982562B
ZA982562B ZA982562A ZA982562A ZA982562B ZA 982562 B ZA982562 B ZA 982562B ZA 982562 A ZA982562 A ZA 982562A ZA 982562 A ZA982562 A ZA 982562A ZA 982562 B ZA982562 B ZA 982562B
Authority
ZA
South Africa
Prior art keywords
chemically
thermally stable
norastemizole
formulations
norastemizole formulations
Prior art date
Application number
ZA982562A
Other languages
English (en)
Inventor
Martin P Redmon
Hal T Butler
Stephen A Wald
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of ZA982562B publication Critical patent/ZA982562B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA982562A 1997-03-26 1998-03-26 Chemically and thermally stable norastemizole formulations ZA982562B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US85178697A 1997-05-06 1997-05-06

Publications (1)

Publication Number Publication Date
ZA982562B true ZA982562B (en) 1998-10-01

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982562A ZA982562B (en) 1997-03-26 1998-03-26 Chemically and thermally stable norastemizole formulations

Country Status (13)

Country Link
EP (1) EP1035869A1 (xx)
JP (1) JP2002512614A (xx)
KR (1) KR20010005746A (xx)
CN (1) CN1257431A (xx)
AR (1) AR012187A1 (xx)
BR (1) BR9808428A (xx)
CA (1) CA2284705A1 (xx)
HU (1) HUP0001823A3 (xx)
NO (1) NO994655L (xx)
NZ (3) NZ517472A (xx)
RU (1) RU2214245C2 (xx)
WO (1) WO1998042379A2 (xx)
ZA (1) ZA982562B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (cs) 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EP2201982A1 (en) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
EA201270309A1 (ru) * 2009-08-24 2012-07-30 Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты Таблетки отилония, полученные прямым прессованием

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3781173T2 (de) * 1986-02-03 1992-12-17 Janssen Pharmaceutica Nv N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen.
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4394931T1 (de) * 1992-09-03 1995-07-20 Sepracor Inc Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
PT920425E (pt) * 1995-11-17 2003-07-31 Aventis Pharma Inc 4-(1h-benzimidazol-2-il-amino)piperidinas substituidas uteis para o tratamento de doencas alergicas
EP0920315B1 (en) * 1996-08-16 2005-12-28 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Also Published As

Publication number Publication date
HUP0001823A3 (en) 2002-04-29
RU2214245C2 (ru) 2003-10-20
WO1998042379A3 (en) 2001-03-01
NO994655D0 (no) 1999-09-24
CN1257431A (zh) 2000-06-21
NZ517472A (en) 2003-08-29
HUP0001823A2 (hu) 2001-04-28
AU6868098A (en) 1998-10-20
EP1035869A1 (en) 2000-09-20
BR9808428A (pt) 2000-05-23
CA2284705A1 (en) 1998-10-01
AR012187A1 (es) 2000-09-27
NO994655L (no) 1999-11-15
AU735257B2 (en) 2001-07-05
NZ527200A (en) 2004-12-24
KR20010005746A (ko) 2001-01-15
JP2002512614A (ja) 2002-04-23
NZ527201A (en) 2004-12-24
WO1998042379A2 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
HK1030747A1 (en) Stable insulin formulations
PL340396A1 (en) Thermally stable polyetheramines
HUP9900812A3 (en) Thermally stabilized contrast agent
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
IL130476A (en) Stable glassy state powder formulations
PL339919A1 (en) Stable cosmetic compositions
ZA9811461B (en) New formulation
GB9717598D0 (en) Novel composition and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HK1026429A1 (en) New formulation
EP0934749A4 (en) ARTICLE SUPPORT ELEMENT AND ARTICLE PROVIDED WITH SAME
HUP9900651A3 (en) Thermally stable antistatic agent and antistatic composition comprising this agent
SI0884053T1 (en) Stable insulin formulations
GB9725946D0 (en) Lipid compositions and their use
GB2367749B (en) Depilatory compositions and their use
ZA982562B (en) Chemically and thermally stable norastemizole formulations
ZA9810773B (en) Revitalisation formulation
GB9718636D0 (en) Novel composition and use
GB9706957D0 (en) Formulation
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
PL341293A1 (en) Beta-lypothropin and application thereof
GB9722392D0 (en) Composition and use
GB9712961D0 (en) Composition and use
GB9703100D0 (en) Formulations
GB9703099D0 (en) Formulations